All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.

@article{Tabr2002AllcauseMA,
  title={All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.},
  author={L{\'a}szl{\'o} K. Tab{\'a}r and Stephen W. Duffy and M. F. Amy Yen and Jane Warwick and Bedrich Vitak and Hsiu-Hsi Chen and Robert A. Smith},
  journal={Journal of medical screening},
  year={2002},
  volume={9 4},
  pages={159-62}
}
BACKGROUND It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women… CONTINUE READING